FLAURA-话题@MedSci - 梅斯（MedSci）

#FLAURA#

9篇内容 | 1002人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2040499, encodeId=9c832040499b5, content=<a href='/topic/show?id=8289e49017' target=_blank style='color:#2F92EE;'>#FLAURA#</a>, objectTitle=Target Oncol:FLAURA中国研究表明一线奥希替尼治疗较吉非替尼改善中国人群EGFR突变NSCLC患者的预后, objectType=article, longId=295592, objectId=e4e3295592aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4e3295592aa, replyNumber=0, likeNumber=86, createdTime=2022-10-15, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4e3295592aa, moduleTitle=Target Oncol:FLAURA中国研究表明一线奥希替尼治疗较吉非替尼改善中国人群EGFR突变NSCLC患者的预后, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e4e3295592aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040497, encodeId=dd01204049ef0, content=<a href='/topic/show?id=8289e49017' target=_blank style='color:#2F92EE;'>#FLAURA#</a>, objectTitle=再读FLAURA研究：从统计学视角解读OS更新结果, objectType=article, longId=190134, objectId=32e0190134cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32e0190134cf, replyNumber=0, likeNumber=61, createdTime=2020-12-06, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32e0190134cf, moduleTitle=再读FLAURA研究：从统计学视角解读OS更新结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=32e0190134cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040498, encodeId=acd3204049843, content=<a href='/topic/show?id=8289e49017' target=_blank style='color:#2F92EE;'>#FLAURA#</a>, objectTitle=AACR 2020：基于ctDNA的复合型预测模型有效预测EGFR突变阳性晚期NSCLC一线治疗PFS（FLAURA研究）, objectType=article, longId=193345, objectId=a58619334571, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a58619334571, replyNumber=0, likeNumber=79, createdTime=2020-12-18, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a58619334571, moduleTitle=AACR 2020：基于ctDNA的复合型预测模型有效预测EGFR突变阳性晚期NSCLC一线治疗PFS（FLAURA研究）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a58619334571)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040496, encodeId=36c6204049618, content=<a href='/topic/show?id=8289e49017' target=_blank style='color:#2F92EE;'>#FLAURA#</a>, objectTitle=喜大普奔 | III期FLAURA 研究OS取得阳性结果，EGFR突变晚期非小细胞肺癌一线标准治疗已成定论, objectType=article, longId=177574, objectId=06bb1e7574a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06bb1e7574a5, replyNumber=0, likeNumber=83, createdTime=2020-07-16, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06bb1e7574a5, moduleTitle=喜大普奔 | III期FLAURA 研究OS取得阳性结果，EGFR突变晚期非小细胞肺癌一线标准治疗已成定论, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=06bb1e7574a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040495, encodeId=cb80204049532, content=<a href='/topic/show?id=8289e49017' target=_blank style='color:#2F92EE;'>#FLAURA#</a>, objectTitle=基于生存预测模型，对FLAURA研究OS数据进行预测, objectType=article, longId=167063, objectId=921c16e0634a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=921c16e0634a, replyNumber=0, likeNumber=82, createdTime=2020-02-06, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=921c16e0634a, moduleTitle=基于生存预测模型，对FLAURA研究OS数据进行预测, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=921c16e0634a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040494, encodeId=753b204049454, content=<a href='/topic/show?id=8289e49017' target=_blank style='color:#2F92EE;'>#FLAURA#</a>, objectTitle=【ESMO Asia】FLAURA研究奠定奥希替尼一线标准治疗地位, objectType=article, longId=121278, objectId=c84a1212e86d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c84a1212e86d, replyNumber=0, likeNumber=78, createdTime=2018-04-22, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c84a1212e86d, moduleTitle=【ESMO Asia】FLAURA研究奠定奥希替尼一线标准治疗地位, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c84a1212e86d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040491, encodeId=0ce22040491ac, content=<a href='/topic/show?id=8289e49017' target=_blank style='color:#2F92EE;'>#FLAURA#</a>, objectTitle=【WCLC 2017】FLAURA研究伴随诊断结果公布：血浆EGFR突变阳性与组织阳性患者接受奥希替尼一线治疗获益一致, objectType=article, longId=116656, objectId=7181116656ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7181116656ed, replyNumber=0, likeNumber=83, createdTime=2018-02-13, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7181116656ed, moduleTitle=【WCLC 2017】FLAURA研究伴随诊断结果公布：血浆EGFR突变阳性与组织阳性患者接受奥希替尼一线治疗获益一致, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7181116656ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040492, encodeId=082a2040492e7, content=<a href='/topic/show?id=8289e49017' target=_blank style='color:#2F92EE;'>#FLAURA#</a>, objectTitle=【ESMO Asia】FLAURA研究：奥希替尼显著降低脑转移患者进展和死亡风险, objectType=article, longId=120687, objectId=615212068e26, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=615212068e26, replyNumber=0, likeNumber=84, createdTime=2018-10-29, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=615212068e26, moduleTitle=【ESMO Asia】FLAURA研究：奥希替尼显著降低脑转移患者进展和死亡风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=615212068e26)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040493, encodeId=6fc3204049304, content=<a href='/topic/show?id=8289e49017' target=_blank style='color:#2F92EE;'>#FLAURA#</a>, objectTitle=【ESMO Asia】FLAURA研究：奥希替尼显著延长PFS及ORR, objectType=article, longId=120734, objectId=3f0d120e34d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f0d120e34d1, replyNumber=0, likeNumber=101, createdTime=2018-06-15, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f0d120e34d1, moduleTitle=【ESMO Asia】FLAURA研究：奥希替尼显著延长PFS及ORR, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3f0d120e34d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

FLAURA

2020-05-29

rebeccajiejie (审核中...)

前往app查看评论内容

#FLAURA#

Target Oncol:FLAURA中国研究表明一线奥希替尼治疗较吉非替尼改善中国人群EGFR突变NSCLC患者的预后

2022-10-15

rebeccajiejie (审核中...)

前往app查看评论内容

#FLAURA#

再读FLAURA研究：从统计学视角解读OS更新结果

2020-12-06

rebeccajiejie (审核中...)

前往app查看评论内容

#FLAURA#

AACR 2020：基于ctDNA的复合型预测模型有效预测EGFR突变阳性晚期NSCLC一线治疗PFS（FLAURA研究）

2020-12-18

rebeccajiejie (审核中...)

前往app查看评论内容

#FLAURA#

喜大普奔 | III期FLAURA 研究OS取得阳性结果，EGFR突变晚期非小细胞肺癌一线标准治疗已成定论

2020-07-16

rebeccajiejie (审核中...)

前往app查看评论内容

#FLAURA#

基于生存预测模型，对FLAURA研究OS数据进行预测

2020-02-06

rebeccajiejie (审核中...)

前往app查看评论内容

#FLAURA#

【ESMO Asia】FLAURA研究奠定奥希替尼一线标准治疗地位

2018-04-22

rebeccajiejie (审核中...)

前往app查看评论内容

#FLAURA#

【WCLC 2017】FLAURA研究伴随诊断结果公布：血浆EGFR突变阳性与组织阳性患者接受奥希替尼一线治疗获益一致

2018-02-13

rebeccajiejie (审核中...)

前往app查看评论内容

#FLAURA#

【ESMO Asia】FLAURA研究：奥希替尼显著降低脑转移患者进展和死亡风险

2018-10-29

rebeccajiejie (审核中...)

前往app查看评论内容

#FLAURA#

【ESMO Asia】FLAURA研究：奥希替尼显著延长PFS及ORR

2018-06-15

科室
- - 订阅+
  - 更多科室
工具
服务